标题
Strategies to Target ADAM17 in Disease: From Its Discovery to the iRhom Revolution
作者
关键词
-
出版物
MOLECULES
Volume 26, Issue 4, Pages 944
出版商
MDPI AG
发表日期
2021-02-13
DOI
10.3390/molecules26040944
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Substrate‐selective protein ectodomain shedding by ADAM17 and iRhom2 depends on their juxtamembrane and transmembrane domains
- (2020) Beiyu Tang et al. FASEB JOURNAL
- ADAM17 stabilizes its interacting partner inactive Rhomboid 2 (iRhom2) but not inactive Rhomboid 1 (iRhom1)
- (2020) Gisela Weskamp et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Novel ADAM-17 inhibitor ZLDI-8 inhibits the metastasis of hepatocellular carcinoma by reversing epithelial-mesenchymal transition in vitro and in vivo
- (2020) Hong-Yuan Lu et al. LIFE SCIENCES
- A Bispecific Inhibitor of the EGFR/ADAM17 Axis Decreases Cell Proliferation and Migration of EGFR-Dependent Cancer Cells
- (2020) Abel Soto-Gamez et al. Cancers
- Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
- (2020) Vanessa Monteil et al. CELL
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System
- (2020) Mahmoud Gheblawi et al. CIRCULATION RESEARCH
- Recent developments and strategies for the discovery of TACE inhibitors
- (2020) Prashant R. Murumkar et al. Expert Opinion on Drug Discovery
- COVID-19 cytokine storm: the interplay between inflammation and coagulation
- (2020) Ricardo J Jose et al. Lancet Respiratory Medicine
- Expression of SARS-CoV-2 receptor, ACE2, and TMPRSS2 in the lung airways is lower in children compared to adults and increases due to smoking and COPD
- (2020) Narjes Saheb Sharif-Askari et al. Molecular Therapy-Methods & Clinical Development
- Challenges in Matrix Metalloproteinases Inhibition
- (2020) Helena Laronha et al. Biomolecules
- Negatively charged amino acids in the stalk region of membrane proteins reduce ectodomain shedding
- (2020) Ryo Iwagishi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Aggrecanase-selective tissue inhibitor of metalloproteinase-3 (TIMP3) protects articular cartilage in a surgical mouse model of osteoarthritis
- (2020) Hiroyuki Nakamura et al. Scientific Reports
- TIMP-3 facilitates binding of target metalloproteinases to the endocytic receptor LRP-1 and promotes scavenging of MMP-1
- (2020) Anna P. Carreca et al. Scientific Reports
- Alpha‐1‐antitrypsin : A possible host protective factor against Covid‐19
- (2020) Mariana Braccialli Loyola et al. REVIEWS IN MEDICAL VIROLOGY
- Epigenetic Regulation of a Disintegrin and Metalloproteinase (ADAM) Transcription in Colorectal Cancer Cells: Involvement of β-Catenin, BRG1, and KDM4
- (2020) Lina Sun et al. Frontiers in Cell and Developmental Biology
- The role of NF-κB and Elk-1 in the regulation of mouse ADAM17 expression
- (2019) Karolina Wawro et al. Biology Open
- The molecular, cellular and pathophysiological roles of iRhom pseudoproteases
- (2019) Iqbal Dulloo et al. Open Biology
- Loss of RHBDF2 results in an early‐onset spontaneous murine colitis
- (2019) Ramasatyaveni Geesala et al. JOURNAL OF LEUKOCYTE BIOLOGY
- ADAM17-deficiency on microglia but not on macrophages promotes phagocytosis and functional recovery after spinal cord injury
- (2019) Daniela Sommer et al. BRAIN BEHAVIOR AND IMMUNITY
- Functional Characterization of Colon Cancer-Associated Mutations in ADAM17: Modifications in the Pro-Domain Interfere with Trafficking and Maturation
- (2019) Egor Pavlenko et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Degradome of soluble ADAM10 and ADAM17 metalloproteases
- (2019) Franka Scharfenberg et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Functions of ‘A disintegrin and metalloproteases (ADAMs)’ in the mammalian nervous system
- (2019) Hung-En Hsia et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- A Novel TNF-α Converting Enzyme (TACE) Selective Inhibitor JTP-96193 Prevents Insulin Resistance in KK-Ay Type 2 Diabetic Mice and Diabetic Peripheral Neuropathy in Type 1 Diabetic Mice
- (2019) Mariko Maekawa et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Novel ADAM-17 inhibitor ZLDI-8 inhibits the proliferation and metastasis of chemo-resistant non-small-cell lung cancer by reversing Notch and epithelial mesenchymal transition in vitro and in vivo
- (2019) Hong-Yuan Lu et al. PHARMACOLOGICAL RESEARCH
- ADAM17 Activity and IL-6 Trans-Signaling in Inflammation and Cancer
- (2019) Schumacher et al. Cancers
- Proteolytic processing of PD-L1 by ADAM proteases in breast cancer cells
- (2019) Yeni Romero et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Discovery and process development of a novel TACE inhibitor for the topical treatment of psoriasis
- (2018) Jean-Guy Boiteau et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Blood-induced bone loss in murine hemophilic arthropathy is prevented by blocking the iRhom2/ADAM17/TNFα pathway
- (2018) Coline Haxaire et al. BLOOD
- ADAM metalloproteinases as potential drug targets
- (2018) Caterina Camodeca et al. CURRENT MEDICINAL CHEMISTRY
- Proteolytic ectodomain shedding of membrane proteins in mammals—hardware, concepts, and recent developments
- (2018) Stefan F Lichtenthaler et al. EMBO JOURNAL
- iRhom2 promotes lupus nephritis through TNF-α and EGFR signaling
- (2018) Xiaoping Qing et al. JOURNAL OF CLINICAL INVESTIGATION
- ADAM17 is required for EGF-R–induced intestinal tumors via IL-6 trans-signaling
- (2018) Stefanie Schmidt et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The EGFR-ADAM17 Axis in Chronic Obstructive Pulmonary Disease and Cystic Fibrosis Lung Pathology
- (2018) Marta Stolarczyk et al. MEDIATORS OF INFLAMMATION
- A rare loss-of-function variant of ADAM17 is associated with late-onset familial Alzheimer disease
- (2018) Daniela Hartl et al. MOLECULAR PSYCHIATRY
- Novel ADAM-17 inhibitor ZLDI-8 enhances the in vitro and in vivo chemotherapeutic effects of Sorafenib on hepatocellular carcinoma cells
- (2018) Yingshi Zhang et al. Cell Death & Disease
- FRMD8 promotes inflammatory and growth factor signalling by stabilising the iRhom/ADAM17 sheddase complex
- (2018) Ulrike Künzel et al. eLife
- iTAP, a novel iRhom interactor, controls TNF secretion by policing the stability of iRhom/TACE
- (2018) Ioanna Oikonomidi et al. eLife
- A novel inhibitor of ADAM17 sensitizes colorectal cancer cells to 5-Fluorouracil by reversing Notch and epithelial-mesenchymal transition in vitro and in vivo
- (2018) Dan-Dan Li et al. CELL PROLIFERATION
- Specific inhibition of ADAM17/TACE promotes neurogenesis in the injured motor cortex
- (2018) Noelia Geribaldi-Doldán et al. Cell Death & Disease
- Increased TIMP-3 expression alters the cellular secretome through dual inhibition of the metalloprotease ADAM10 and ligand-binding of the LRP-1 receptor
- (2018) Simone D. Scilabra et al. Scientific Reports
- IL-6 inhibitor for the treatment of rheumatoid arthritis: A comprehensive review
- (2018) Atsushi Ogata et al. Modern Rheumatology
- Tyrosine phosphorylation directs TACE into extracellular vesicles via unconventional secretion
- (2018) Zhe Zhao et al. TRAFFIC
- Structural modeling defines transmembrane residues in ADAM17 that are crucial for Rhbdf2–ADAM17-dependent proteolysis
- (2017) Xue Li et al. JOURNAL OF CELL SCIENCE
- Recent Advances in ADAM17 Research: A Promising Target for Cancer and Inflammation
- (2017) Marcia L. Moss et al. MEDIATORS OF INFLAMMATION
- Elements of cancer immunity and the cancer–immune set point
- (2017) Daniel S. Chen et al. NATURE
- The role of IL-6 in host defence against infections: immunobiology and clinical implications
- (2017) Stefan Rose-John et al. Nature Reviews Rheumatology
- ADAM17 is the main sheddase for the generation of human triggering receptor expressed in myeloid cells (hTREM2) ectodomain and cleaves TREM2 after Histidine 157
- (2017) Dominik Feuerbach et al. NEUROSCIENCE LETTERS
- Targeting ADAM17 inhibits human colorectal adenocarcinoma progression and tumor-initiating cell frequency
- (2017) Joseph Dosch et al. Oncotarget
- Phosphorylation of iRhom2 Controls Stimulated Proteolytic Shedding by the Metalloprotease ADAM17/TACE
- (2017) Miguel Cavadas et al. Cell Reports
- Phosphorylation of iRhom2 at the plasma membrane controls mammalian TACE-dependent inflammatory and growth factor signalling
- (2017) Adam Graham Grieve et al. eLife
- Inhibition of Shedding of Low-Density Lipoprotein Receptor-Related Protein 1 Reverses Cartilage Matrix Degradation in Osteoarthritis
- (2017) Kazuhiro Yamamoto et al. Arthritis & Rheumatology
- Hepatocyte specific TIMP3 expression prevents diet dependent fatty liver disease and hepatocellular carcinoma
- (2017) Viviana Casagrande et al. Scientific Reports
- Adam17 Deficiency Promotes Atherosclerosis by Enhanced TNFR2 Signaling in MiceHighlights
- (2016) Alexandros Nicolaou et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Stimulated release and functional activity of surface expressed metalloproteinase ADAM17 in exosomes
- (2016) Esther Groth et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Novel Insights in the Regulation of Phosphatidylserine Exposure in Human Red Blood Cells
- (2016) Mauro C. Wesseling et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Targeting ADAM17 Sheddase Activity in Cancer
- (2016) Armando Rossello et al. CURRENT DRUG TARGETS
- Anti-TNF-α therapies for the treatment of Crohn’s disease: the past, present and future
- (2016) Marc Berns et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Molecular basis for the mechanism of action of an anti-TACE antibody
- (2016) Li Peng et al. mAbs
- MMP-13 is constitutively produced in human chondrocytes and co-endocytosed with ADAMTS-5 and TIMP-3 by the endocytic receptor LRP1
- (2016) Kazuhiro Yamamoto et al. MATRIX BIOLOGY
- Developing anti-inflammatory therapeutics for patients with osteoarthritis
- (2016) Ashleigh M. Philp et al. RHEUMATOLOGY
- Phosphatidylserine exposure is required for ADAM17 sheddase function
- (2016) Anselm Sommer et al. Nature Communications
- Harnessing the natural inhibitory domain to control TNFα Converting Enzyme (TACE) activity in vivo
- (2016) Eitan Wong et al. Scientific Reports
- Selective Inhibition of ADAM17 Efficiently Mediates Glycoprotein Ibα Retention During Ex Vivo Generation of Human Induced Pluripotent Stem Cell-Derived Platelets
- (2016) Shinji Hirata et al. Stem Cells Translational Medicine
- Epithelial Cell-Derived a Disintegrin and Metalloproteinase-17 Confers Resistance to Colonic Inflammation Through EGFR Activation
- (2016) Masayuki Shimoda et al. EBioMedicine
- Targeting ADAM-17 with an inhibitory monoclonal antibody has antitumour effects in triple-negative breast cancer cells
- (2015) F Caiazza et al. BRITISH JOURNAL OF CANCER
- iRhoms in the brain – a new frontier?
- (2015) Stefan F Lichtenthaler et al. CELL CYCLE
- Adam17, a Target of Mir-326, Promotes Emt-Induced Cells Invasion in Lung Adenocarcinoma
- (2015) Ming Cai et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- A metal-based tumour necrosis factor-alpha converting enzyme inhibitor
- (2015) Chung-Hang Leung et al. CHEMICAL COMMUNICATIONS
- The Functional Maturation of A Disintegrin and Metalloproteinase (ADAM) 9, 10, and 17 Requires Processing at a Newly Identified Proprotein Convertase (PC) Cleavage Site
- (2015) Eitan Wong et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- ADAM17 controls IL-6 signaling by cleavage of the murine IL-6Rα from the cell surface of leukocytes during inflammatory responses
- (2015) Isabell Yan et al. JOURNAL OF LEUKOCYTE BIOLOGY
- SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes
- (2015) Anna M. Knapinska et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Monoclonal Antibody to ADAM17 Inhibits Tumor Growth by Inhibiting EGFR and Non-EGFR-Mediated Pathways
- (2015) J. Rios-Doria et al. MOLECULAR CANCER THERAPEUTICS
- iRhoms 1 and 2 are essential upstream regulators of ADAM17-dependent EGFR signaling
- (2015) Xue Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Design of selective TACE inhibitors using molecular docking studies: Synthesis and preliminary evaluation of anti-inflammatory and TACE inhibitory activity
- (2015) A.P. Sarkate et al. SAR AND QSAR IN ENVIRONMENTAL RESEARCH
- MicroRNA-145 Targets the Metalloprotease ADAM17 and Is Suppressed in Renal Cell Carcinoma Patients
- (2015) Kai Doberstein et al. NEOPLASIA
- MicroRNA-152 targets ADAM17 to suppress NSCLC progression
- (2014) Yunshu Su et al. FEBS LETTERS
- Anti-TNF therapy: past, present and future
- (2014) C. Monaco et al. INTERNATIONAL IMMUNOLOGY
- Low Density Lipoprotein Receptor-related Protein 1 (LRP1)-mediated Endocytic Clearance of a Disintegrin and Metalloproteinase with Thrombospondin Motifs-4 (ADAMTS-4)
- (2014) Kazuhiro Yamamoto et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Therapeutic Targeting of IL-6 Trans Signaling Counteracts STAT3 Control of Experimental Inflammatory Arthritis
- (2014) M. A. Nowell et al. JOURNAL OF IMMUNOLOGY
- Alzheimer's disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci
- (2014) Philip L De Jager et al. NATURE NEUROSCIENCE
- IL-6 biology: implications for clinical targeting in rheumatic disease
- (2014) Leonard H. Calabrese et al. Nature Reviews Rheumatology
- Microglia actions in Alzheimer’s disease
- (2013) Stefan Prokop et al. ACTA NEUROPATHOLOGICA
- Glycosylation of a disintegrin and metalloprotease 17 affects its activity and inhibition
- (2013) Anais Chavaroche et al. ANALYTICAL BIOCHEMISTRY
- Analysis of cognition, motor performance and anxiety in young and aged tumor necrosis factor alpha receptor 1 and 2 deficient mice
- (2013) Petrus J.W. Naude et al. BEHAVIOURAL BRAIN RESEARCH
- NK cell CD16 surface expression and function is regulated by a disintegrin and metalloprotease-17 (ADAM17)
- (2013) R. Romee et al. BLOOD
- Human breast cancer-associated fibroblasts enhance cancer cell proliferation through increased TGF-α cleavage by ADAM17
- (2013) Ming-Qing Gao et al. CANCER LETTERS
- TNF-α Mediates PKR-Dependent Memory Impairment and Brain IRS-1 Inhibition Induced by Alzheimer’s β-Amyloid Oligomers in Mice and Monkeys
- (2013) Mychael V. Lourenco et al. Cell Metabolism
- MicroRNA-124 mediates the cholinergic anti-inflammatory action through inhibiting the production of pro-inflammatory cytokines
- (2013) Yang Sun et al. CELL RESEARCH
- Mammalian iRhoms have distinct physiological functions including an essential role in TACE regulation
- (2013) Yonka Christova et al. EMBO REPORTS
- miR-145 suppresses cell invasion in hepatocellular carcinoma cells: miR-145 targets ADAM17
- (2013) Xue-wei Yang et al. HEPATOLOGY RESEARCH
- TACE-dependent TGFα shedding drives triple-negative breast cancer cell invasion
- (2013) Orsi Giricz et al. INTERNATIONAL JOURNAL OF CANCER
- TNFR2 Is Critical for the Stabilization of the CD4+Foxp3+ Regulatory T Cell Phenotype in the Inflammatory Environment
- (2013) X. Chen et al. JOURNAL OF IMMUNOLOGY
- ADAM17 silencing by adenovirus encoding miRNA-embedded siRNA revealed essential signal transduction by angiotensin II in vascular smooth muscle cells
- (2013) Katherine J. Elliott et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- ADAM17 Controls Endochondral Ossification by Regulating Terminal Differentiation of Chondrocytes
- (2013) Katherine C. Hall et al. MOLECULAR AND CELLULAR BIOLOGY
- iRhom2 controls the substrate selectivity of stimulated ADAM17-dependent ectodomain shedding
- (2013) T. Maretzky et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- ADAM17 cleaves CD16b (FcγRIIIb) in human neutrophils
- (2012) Yue Wang et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- TIMP3 Overexpression in Macrophages Protects From Insulin Resistance, Adipose Inflammation, and Nonalcoholic Fatty Liver Disease in Mice
- (2012) R. Menghini et al. DIABETES
- Lung endothelial ADAM17 regulates the acute inflammatory response to lipopolysaccharide
- (2012) Daniela Dreymueller et al. EMBO Molecular Medicine
- Signaling pathways used by EGF to stimulate conjunctival goblet cell secretion
- (2012) Robin R. Hodges et al. EXPERIMENTAL EYE RESEARCH
- LRP-1-mediated endocytosis regulates extracellular activity of ADAMTS-5 in articular cartilage
- (2012) Kazuhiro Yamamoto et al. FASEB JOURNAL
- The ADAM family
- (2012) Laura Christian FLY
- Notch Activation by the Metalloproteinase ADAM17 Regulates Myeloproliferation and Atopic Barrier Immunity by Suppressing Epithelial Cytokine Synthesis
- (2012) Aditya Murthy et al. IMMUNITY
- Discovery of Novel Inhibitors of a Disintegrin and Metalloprotease 17 (ADAM17) Using Glycosylated and Non-glycosylated Substrates
- (2012) Dmitriy Minond et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Epidermal ADAM17 maintains the skin barrier by regulating EGFR ligand–dependent terminal keratinocyte differentiation
- (2012) Claus-Werner Franzke et al. JOURNAL OF CELL BIOLOGY
- MiR-145 reduces ADAM17 expression and inhibits in vitro migration and invasion of glioma cells
- (2012) YONG LU et al. ONCOLOGY REPORTS
- Interleukin-1 Stimulates ADAM17 through a Mechanism Independent of its Cytoplasmic Domain or Phosphorylation at Threonine 735
- (2012) Katherine C. Hall et al. PLoS One
- ADAM17 Silencing in Mouse Colon Carcinoma Cells: The Effect on Tumoricidal Cytokines and Angiogenesis
- (2012) Sudipta Das et al. PLoS One
- Tumor Necrosis Factor Signaling Requires iRhom2 to Promote Trafficking and Activation of TACE
- (2012) C. Adrain et al. SCIENCE
- iRhom2 Regulation of TACE Controls TNF-Mediated Protection Against Listeria and Responses to LPS
- (2012) D. R. McIlwain et al. SCIENCE
- TACE Activation by MAPK-Mediated Regulation of Cell Surface Dimerization and TIMP3 Association
- (2012) P. Xu et al. Science Signaling
- Ablation of TNF-RI/RII Expression in Alzheimer's Disease Mice Leads to an Unexpected Enhancement of Pathology
- (2011) Sara L. Montgomery et al. AMERICAN JOURNAL OF PATHOLOGY
- Overexpression of Tissue Inhibitor of Metalloproteinase 3 in Macrophages Reduces Atherosclerosis in Low-Density Lipoprotein Receptor Knockout Mice
- (2011) Viviana Casagrande et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- TNFR1-induced activation of the classical NF-κB pathway
- (2011) Harald Wajant et al. FEBS Journal
- COGNITIVE IMPROVEMENT WITH INTRATHECAL ADMINISTRATION OF INFLIXIMAB IN A WOMAN WITH ALZHEIMER'S DISEASE
- (2011) Jian-Quan Shi et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Inflammatory Skin and Bowel Disease Linked toADAM17Deletion
- (2011) Diana C. Blaydon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Leukocyte ADAM17 Regulates Acute Pulmonary Inflammation
- (2011) Patrick G. Arndt et al. PLoS One
- Cross-domain inhibition of TACE ectodomain
- (2011) C. J. Tape et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TNF-α–Converting Enzyme/A Disintegrin and Metalloprotease−17 Mediates Mechanotransduction in Murine Tracheal Epithelial Cells
- (2010) Tetsuya Shiomi et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Reactive-site mutants of N-TIMP-3 that selectively inhibit ADAMTS-4 and ADAMTS-5: biological and structural implications
- (2010) Ngee H. Lim et al. BIOCHEMICAL JOURNAL
- Thiol isomerases negatively regulate the cellular shedding activity of ADAM17
- (2010) Sofie H. Willems et al. BIOCHEMICAL JOURNAL
- The tissue inhibitors of metalloproteinases (TIMPs): An ancient family with structural and functional diversity
- (2010) Keith Brew et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Novel TNF-α converting enzyme (TACE) inhibitors as potential treatment for inflammatory diseases
- (2010) Vinay M. Girijavallabhan et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Clinical Benefit of INCB7839, a Potent and Selective Inhibitor of ADAM10 and ADAM17, in Combination with Trastuzumab in Metastatic HER2 Positive Breast Cancer Patients.
- (2010) S. Friedman et al. CANCER RESEARCH
- Pathological Neovascularization Is Reduced by Inactivation of ADAM17 in Endothelial Cells but Not in Pericytes
- (2010) Gisela Weskamp et al. CIRCULATION RESEARCH
- Enhand secretion of tumour necrosis factor-alpha, IL-6, and IL-1β by isolated lamina ropria monouclear cells from patients with ulcretive cilitis and Crohn's disease
- (2010) H.-C. REINECKER et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- ADAM10 is the physiologically relevant, constitutive α-secretase of the amyloid precursor protein in primary neurons
- (2010) Peer-Hendrik Kuhn et al. EMBO JOURNAL
- The “A Disintegrin And Metalloproteases” ADAM10 and ADAM17: Novel drug targets with therapeutic potential?
- (2010) Paul Saftig et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- ADAM17 is regulated by a rapid and reversible mechanism that controls access to its catalytic site
- (2010) S. M. Le Gall et al. JOURNAL OF CELL SCIENCE
- Critical role of the disintegrin metalloprotease ADAM17 for intestinal inflammation and regeneration in mice
- (2010) Athena Chalaris et al. JOURNAL OF EXPERIMENTAL MEDICINE
- In vivo role of leukocyte ADAM17 in the inflammatory and host responses during E. coli -mediated peritonitis
- (2010) Chunmei Long et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Inflammatory mediators promote production of shed LRP1/CD91, which regulates cell signaling and cytokine expression by macrophages
- (2010) Matvey Gorovoy et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Role of proinflammatory cytokines in the pathophysiology of osteoarthritis
- (2010) Mohit Kapoor et al. Nature Reviews Rheumatology
- Active-site determinants of substrate recognition by the metalloproteinases TACE and ADAM10
- (2009) Cristina I. Caescu et al. BIOCHEMICAL JOURNAL
- Decreased behavioral impairments in an Alzheimer mice model by interfering with TNF-alpha metabolism
- (2009) Fabienne Giuliani et al. BRAIN RESEARCH BULLETIN
- Conditional Inactivation of TACE by a Sox9 Promoter Leads to Osteoporosis and Increased Granulopoiesis via Dysregulation of IL-17 and G-CSF
- (2009) K. Horiuchi et al. JOURNAL OF IMMUNOLOGY
- Microglia Protect Neurons against Ischemia by Synthesis of Tumor Necrosis Factor
- (2009) K. L. Lambertsen et al. JOURNAL OF NEUROSCIENCE
- LRP1 shedding in human brain: roles of ADAM10 and ADAM17
- (2009) Qiang Liu et al. Molecular Neurodegeneration
- Role for TNF in atherosclerosis? Lessons from autoimmune disease
- (2009) Gayle E. McKellar et al. Nature Reviews Cardiology
- Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis
- (2009) Peter C. Taylor et al. Nature Reviews Rheumatology
- Inhibition of soluble TNF signaling in a mouse model of Alzheimer's disease prevents pre-plaque amyloid-associated neuropathology
- (2009) Fiona E. McAlpine et al. NEUROBIOLOGY OF DISEASE
- The Second Dimer Interface of MT1-MMP, the Transmembrane Domain, Is Essential for ProMMP-2 Activation on the Cell Surface
- (2008) Yoshifumi Itoh et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Structural Determinants of the ADAM Inhibition by TIMP-3: Crystal Structure of the TACE-N-TIMP-3 Complex
- (2008) Magdalena Wisniewska et al. JOURNAL OF MOLECULAR BIOLOGY
- Persistent transactivation of EGFR and ErbB2/HER2 by protease-activated receptor-1 promotes breast carcinoma cell invasion
- (2008) P Arora et al. ONCOGENE
- Modulation of TNF- -converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF- production and facilitates viral entry
- (2008) S. Haga et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Clipping, shedding and RIPping keep immunity on cue
- (2008) Gillian Murphy et al. TRENDS IN IMMUNOLOGY
- Mapping and characterization of the functional epitopes of tissue inhibitor of metalloproteinases (TIMP)-3 using TIMP-1 as the scaffold: A new frontier in TIMP engineering
- (2002) Meng-Huee Lee et al. PROTEIN SCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now